Skip to main content Help with accessibility Skip to main navigation

Melatonin prolonged release tablets (Circadin® and Slenyto®) for the treatment of persistent chronic sleep disorders in adults and children

CCG Approval Status:

Date Added: 23 - Sep - 2021
Body System:
Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of melatonin prolonged release tablets (Circadin® and Slenyto®) for the treatment of persistent chronic sleep disorders in the circumstances where sleep hygiene measures have been insufficient.

Management of sleep disorders in children and adults - flowchart